These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6687694

  • 21. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Villani F, Busia A, Villani M, Laffranchi A, Viviani S, Bonfante V.
    Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
    [Abstract] [Full Text] [Related]

  • 22. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
    Matusewicz W, Drzewoski J, Robak T, Krykowski E.
    Kardiol Pol; 1983 Feb; 26(7):591-4. PubMed ID: 6689036
    [No Abstract] [Full Text] [Related]

  • 23. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Souza EM, Baiocchi OC, Zanichelli MA, Alves AC, Oliveira JS.
    Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
    [Abstract] [Full Text] [Related]

  • 24. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
    Riccardi A, Gobbi P, Danova M, Giordano M, Pieresca C, Bertoloni D, Brugnatelli S, Ascari E.
    Haematologica; 1993 Jul; 78(1):44-8. PubMed ID: 7684012
    [Abstract] [Full Text] [Related]

  • 25. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
    Chow LM, Nathan PC, Hodgson DC, Jenkin D, Weitzman S, Grant RM, Manson D, Bross A, Doyle JJ, Danjoux C, Greenberg ML.
    J Clin Oncol; 2006 Dec 20; 24(36):5735-41. PubMed ID: 17179107
    [Abstract] [Full Text] [Related]

  • 26. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R, Gil-Fernández JJ, Muñoz E, Acevedo A, Sobrino MP, Fernández-Rañada JM.
    Sangre (Barc); 1998 Jun 20; 43(3):179-84. PubMed ID: 9741222
    [Abstract] [Full Text] [Related]

  • 27. [Acute lymphoblastic leukemia L3 in Hodgkin's disease in remission: primary or secondary leukosis?].
    Musto P, Lucchi T, Barbieri D, Ferraresi P, Lanza F.
    Recenti Prog Med; 1985 Apr 20; 76(4):194-8. PubMed ID: 3862191
    [No Abstract] [Full Text] [Related]

  • 28. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cunningham J, Mauch P, Rosenthal DS, Canellos GP.
    Cancer Treat Rep; 1982 Apr 20; 66(4):1015-22. PubMed ID: 7074629
    [Abstract] [Full Text] [Related]

  • 29. [Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults].
    Glanzmann C, Stahel R.
    Praxis (Bern 1994); 1995 Oct 10; 84(41):1140-7. PubMed ID: 7481323
    [Abstract] [Full Text] [Related]

  • 30. [Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
    Balwierz W, Moryl-Bujakowska A, Depowska T, Klekawka T, Stanuch H, Matysiak M, Sopyło B, Kołakowska-Mrozowska B, Krenke K, Chybicka A, Raś M, Sońta-Jakimczyk D, Moszant A, Wachowiak J, Kaczmarek-Kanold M, Kowalczyk J, Odój T, Balcerska A, Drozyńska E, Wysocki M, Kołtan A, Krawczuk-Rybak M, Stolarska M.
    Przegl Lek; 2004 Oct 10; 61 Suppl 2():33-9. PubMed ID: 15688474
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Primary treatment of advanced Hodgkin's disease].
    Illés A, Udvardy M, Molnár Z.
    Orv Hetil; 2005 Jan 30; 146(5):195-202. PubMed ID: 15773586
    [Abstract] [Full Text] [Related]

  • 33. Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
    Brosteanu O, Hasenclever D, Loeffler M, Diehl V, German Hodgkin's Lymphoma Study Group.
    Ann Hematol; 2004 Mar 30; 83(3):176-82. PubMed ID: 15064867
    [Abstract] [Full Text] [Related]

  • 34. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG, Levis A, Chisesi T, Broglia C, Vitolo U, Stelitano C, Pavone V, Cavanna L, Santini G, Merli F, Liberati M, Baldini L, Deliliers GL, Angelucci E, Bordonaro R, Federico M, Intergruppo Italiano Linfomi.
    J Clin Oncol; 2005 Dec 20; 23(36):9198-207. PubMed ID: 16172458
    [Abstract] [Full Text] [Related]

  • 35. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.
    Coltman CA, Dixon DO.
    Cancer Treat Rep; 1982 Apr 20; 66(4):1023-33. PubMed ID: 7074630
    [Abstract] [Full Text] [Related]

  • 36. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J, Macharová H, Pohanková R, Malír A, Coupek P, Konecný M, Patera J, Pecina J, Drbal J, Koukalová H, Vásová I.
    Neoplasma; 2000 Apr 20; 47(2):129-32. PubMed ID: 10985481
    [Abstract] [Full Text] [Related]

  • 37. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, Tirelli U, Monconduit M, Thomas J, Eghbali H, Aleman BM, Bosq J, Vovk M, Verschueren TA, Pény AM, Girinsky T, Raemaekers JM, Henry-Amar M.
    J Clin Oncol; 2006 Jul 01; 24(19):3128-35. PubMed ID: 16754934
    [Abstract] [Full Text] [Related]

  • 38. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
    Pivnik AV, Rastrigin NA, Moiseeva TN, Lutsenko IN, Dudarova RG, Shavlokhov VS, Efimov IV, Kozhurin SV, Shitareva IV, Gemdzhian EG, Tsyba NN, Kolosova LIu, Melikian AL, Skidan NI, Pan'shin GA, Sotnikov VM, Dotsenko PV, Nechistiuk AV.
    Ter Arkh; 2006 Jul 01; 78(8):57-62. PubMed ID: 17078219
    [Abstract] [Full Text] [Related]

  • 39. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM, Raemaekers JM, Tomiŝiĉ R, Baaijens MH, Bortolus R, Lybeert ML, van der Maazen RW, Girinsky T, Demeestere G, Lugtenburg P, Lievens Y, de Jong D, Pinna A, Henry-Amar M, European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):19-30. PubMed ID: 17097834
    [Abstract] [Full Text] [Related]

  • 40. [10 years of DeVita protocol].
    Gassmann W, Schmitz N, Löffler H.
    Dtsch Med Wochenschr; 1982 Jul 09; 107(27):1043-4. PubMed ID: 6896303
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.